Pharma will continue to outperform: Abhishek Singhal of Macquarie
Abhishek Singhal, associate director of research at Macquarie Securities Group, says he expects the pharmaceutical sector to continue to outperform. He also says that he likes Glenmark and Ranbaxy from the space. Mr Singhal also says for Ranbaxy most negatives are factored in.
